FI
Fosun International Portfolio holdings
AUM
$360M
This Quarter Return
+12.61%
1 Year Return
+38.28%
3 Year Return
+3.77%
5 Year Return
+27.59%
10 Year Return
+94.55%
AUM
$1.57B
AUM Growth
-$99.9M
(-6%)
Cap. Flow
-$265M
Cap. Flow
% of AUM
-16.83%
Top 10 Holdings %
Top 10 Hldgs %
52.85%
Holding
343
New
45
Increased
88
Reduced
68
Closed
37
Top Buys
| 1 |
BZUN
Baozun
BZUN
|
$20.3M |
| 2 |
MOMO
Hello Group
MOMO
|
$6.36M |
| 3 |
Bristol-Myers Squibb
BMY
|
$3.97M |
| 4 |
BBU
Brookfield Business Partners
BBU
|
$3.38M |
| 5 |
Neurocrine Biosciences
NBIX
|
$3.34M |
Top Sells
| 1 |
KANG
iKang Healthcare Group, Inc.
KANG
|
$94.3M |
| 2 |
Vipshop
VIPS
|
$53.6M |
| 3 |
DigitalBridge
DBRG
|
$37.5M |
| 4 |
Brookdale Senior Living
BKD
|
$33.9M |
| 5 |
Criteo
CRTO
|
$15.3M |
Sector Composition
| 1 | Healthcare | 37.62% |
| 2 | Financials | 6.46% |
| 3 | Consumer Discretionary | 4.13% |
| 4 | Industrials | 2.9% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Las Vegas Sands
LVS
$38B
| $1.29M | 0.08% |
21,400
+10,500
| +96% | +$633K |
|
127
Qualcomm
QCOM
$170B
| $1.26M | 0.08% |
22,300
+10,000
| +81% | +$565K |
|
128
Spero Therapeutics
SPRO
$117M
| $1.25M | 0.08% |
103,362
-59,000
| -36% | -$712K |
|
129
Schlumberger
SLB
$52.2B
| $1.23M | 0.08% |
28,200
+3,000
| +12% | +$131K |
|
|
PRTK
130
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.23M | 0.08% |
227,383
| – | – |
|
|
CCXI
131
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.22M | 0.08% |
91,776
-9,200
| -9% | -$122K |
|
132
MEI Pharma
MEIP
$149M
| $1.22M | 0.08% |
19,826
| – | – |
|
133
LKQ Corp
LKQ
$8.23B
| $1.21M | 0.08% |
43,000
+5,000
| +13% | +$141K |
|
134
Cintas
CTAS
$82.9B
| $1.2M | 0.08% |
24,000
+7,600
| +46% | +$381K |
|
135
Thermo Fisher Scientific
TMO
$183B
| $1.19M | 0.08% |
4,400
+300
| +7% | +$81.1K |
|
|
MDCO
136
DELISTED
Medicines Co
MDCO
| $1.18M | 0.08% |
42,500
+8,500
| +25% | +$237K |
|
137
Exxon Mobil
XOM
$477B
| $1.18M | 0.07% |
+14,550
| New | +$1.18M |
|
|
TBIO
138
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $1.14M | 0.07% |
115,488
+41,488
| +56% | +$409K |
|
139
Protalix BioTherapeutics
PLX
$128M
| $1.13M | 0.07% |
263,140
| – | – |
|
140
GE Aerospace
GE
$293B
| $1.13M | 0.07% |
22,873
+337
| +1% | +$16.6K |
|
141
Mondelez International
MDLZ
$79.3B
| $1.12M | 0.07% |
22,700
+6,300
| +38% | +$311K |
|
142
IAC Inc
IAC
$2.91B
| $1.12M | 0.07% |
29,656
-1,119
| -4% | -$42.1K |
|
|
EDAP
143
EDAP TMS
EDAP
$103M
| $1.07M | 0.07% |
363,485
+114,342
| +46% | +$337K |
|
144
Amphenol
APH
$135B
| $1.03M | 0.07% |
43,840
| – | – |
|
|
SPPI
145
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.02M | 0.06% |
95,246
-25,754
| -21% | -$275K |
|
146
Philip Morris
PM
$254B
| $1M | 0.06% |
11,500
+3,500
| +44% | +$306K |
|
147
FirstEnergy
FE
$25.1B
| $994K | 0.06% |
24,000
| – | – |
|
148
Mercado Libre
MELI
$120B
| $994K | 0.06% |
+2,000
| New | +$994K |
|
149
APA Corp
APA
$8.11B
| $983K | 0.06% |
28,000
| – | – |
|
150
Lexicon Pharmaceuticals
LXRX
$392M
| $952K | 0.06% |
181,000
+80,379
| +80% | +$423K |
|